Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrew B. Moore"'
Autor:
Kirk A. Stiffler, Susan Malveau, Jeffrey M. Caterino, Scott T. Wilber, Christopher W. Baugh, Robert E. Weiss, Daniel K. Nishijima, Benjamin C. Sun, Deborah B. Diercks, Aveh Bastani, Andrew B. Moore, Annick N. Yagapen, David H. Adler, Judd E. Hollander, Manish N. Shah, Erica Su, Alan B. Storrow, Bret A. Nicks, Carol L. Clark
Publikováno v:
Academic Emergency Medicine. 27:161-164
Autor:
J. Jacob Kulstad, Andrew B. Moore, Robert H. Knopp, Santica M. Marcovina, Subramaniam Pennathur, Tomas Vaisar, Xue Qiao Zhao, John D. Brunzell, Pattie S. Green, Jay W. Heinecke
Publikováno v:
Circulation. 118:1259-1267
Background— Boosting low high-density lipoprotein (HDL) levels is a current strategy for preventing clinical events that result from cardiovascular disease. We previously showed that HDL 3 of subjects with coronary artery disease is enriched in apo
Autor:
Andrew B. Moore, Xue Qiao Zhao, Colin D Lee, J.Theodore Dodge, Binh An P. Phan, Baocheng Chu, Nayak L. Polissar, Frank Bray, Thomas S. Hatsukami, Chun Yuan
Publikováno v:
American Heart Journal. 154:239-246
Background In vivo testing of the lipid depletion hypothesis in human beings during lipid-modifying therapy has not been possible until recent developments in magnetic resonance imaging (MRI). Trial Design The Carotid Plaque Composition Study is a pr
Autor:
Blazej Neradilek, Joseph Davis, Binh An P. Phan, Laura J. Pollan, B. Greg Brown, Xue Qiao Zhao, Andrew B. Moore
Publikováno v:
Journal of clinical lipidology. 8(5)
Studies have documented the short-term vascular benefits of combination lipid therapy.Our objective was to evaluate the long-term effects of combination lipid therapy on carotid intima-media thickness (CIMT) in patients with coronary artery disease.W
Autor:
Xue-Qiao Zhao, Greg B. Brown, Binh An P. Phan, Andrew B. Moore, Chunhua Zheng, Blazej Neradilek, Laura J. Pollan, Joseph T. Davis
Publikováno v:
Journal of Clinical Lipidology. 6:262
average of 18 years. Subsequently, they continued on therapy with simvastatin/ezetimibe (S/E) plus niacin. Carotid ultrasound was performed in 39 active participants at the time of starting (S/E) plus niacin and 2 years after. Bilateral carotid scans